Evidence map›Paper›PMID 38201840›Full record

ReviewNutrients2023

Nutraceutical Properties of Syringic Acid in Civilization Diseases-Review.

Iga Bartel, Izabela Mandryk, Jarosław O Horbańczuk, Agnieszka Wierzbicka, Magdalena Koszarska

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Potential Nutraceutical Properties ofMolecules (Basel, Switzerland) · 2026
    Article
  6. Bioactive Phenolic Compounds from Rambutan (International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Comparative Study on the Mycelium and Fruiting Body ofCurrent issues in molecular biology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Chemical profile ofFrontiers in chemistry · 2025
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Iga BartelInstitute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 05-552 Jastrzębiec, Poland.ORCID 0000-0002-8363-2016
Izabela MandrykFaculty of Medicine and Health Sciences, University of Applied Sciences in Nowy Sacz, 33-300 Nowy Sacz, Poland.ORCID 0000-0002-9251-5030
Jarosław O HorbańczukInstitute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 05-552 Jastrzębiec, Poland.
Agnieszka WierzbickaInstitute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 05-552 Jastrzębiec, Poland.
Magdalena KoszarskaInstitute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 05-552 Jastrzębiec, Poland.
Polish Academy of Sciences · PLPaństwowa Wyższa Szkoła Zawodowa w Nowym Sączu · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Civilization diseases account for a worldwide health issue. They result from daily behavioral, environmental, and genetic factors. One of the most significant opportunities to prevent and alleviate the occurrence of these diseases is a diet rich in antioxidants like polyphenols. This review paper is concentrated on syringic acid (SA), one of the representative compounds of phenolic acids subgroups. There are many in vitro and in vivo studies on SA that assess its pivotal effects on oxidative stress and inflammation parameters. It is effective on metabolic risk factors as well, including hyperglycemia, high blood pressure, and hyperlipidemia. SA is one of the prominent polyphenolic compounds that may help address health issues related to civilization diseases.

Indexed as

Dietary SupplementsGallic AcidAntioxidantsCivilizationAntioxidantsGallic Acidsyringic acidantioxidantsbioactive compoundscivilization diseasesphenolic acidsyringic acid

Identifiers

PMID38201840
PMCPMC10780450
OpenAlexW4389977596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.